<?xml version="1.0" encoding="UTF-8"?>
<ref id="B43-pathogens-09-00432">
 <label>43.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lambdin</surname>
    <given-names>B.H.</given-names>
   </name>
   <name>
    <surname>Lorvick</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Mbwambo</surname>
    <given-names>J.K.</given-names>
   </name>
   <name>
    <surname>Rwegasha</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Hassan</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Lum</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Kral</surname>
    <given-names>A.H.</given-names>
   </name>
  </person-group>
  <article-title>Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania</article-title>
  <source>Int. J. Drug Policy</source>
  <year>2017</year>
  <volume>45</volume>
  <fpage>64</fpage>
  <lpage>69</lpage>
  <pub-id pub-id-type="doi">10.1016/j.drugpo.2017.05.043</pub-id>
  <?supplied-pmid 28628854?>
  <pub-id pub-id-type="pmid">28628854</pub-id>
 </element-citation>
</ref>
